Zealand Pharma AS (ZLDPF)
115.06
-1.00
(-0.86%)
USD |
OTCM |
Nov 14, 09:32
Zealand Pharma Revenue (Quarterly): 0.6506M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.6506M |
| June 30, 2024 | 4.927M |
| March 31, 2024 | 2.198M |
| December 31, 2023 | 3.353M |
| September 30, 2023 | 43.16M |
| June 30, 2023 | 1.521M |
| March 31, 2023 | 1.965M |
| December 31, 2022 | 3.289M |
| September 30, 2022 | 5.918M |
| June 30, 2022 | 3.635M |
| March 31, 2022 | 1.653M |
| December 31, 2021 | 2.066M |
| September 30, 2021 | 8.591M |
| June 30, 2021 | 5.923M |
| March 31, 2021 | 0.9247M |
| December 31, 2020 | -15.69M |
| September 30, 2020 | 8.880M |
| June 30, 2020 | 32.64M |
| March 31, 2020 | 1.833M |
| December 31, 2019 | 1.704M |
| September 30, 2019 | 1.478M |
| June 30, 2019 | 2.997M |
| March 31, 2019 | |
| December 31, 2018 | 2.006M |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | 2.425M |
| March 31, 2018 | 1.604M |
| December 31, 2017 | 1.665M |
| September 30, 2017 | 6.177M |
| June 30, 2017 | 1.475M |
| March 31, 2017 | 11.12M |
| December 31, 2016 | 25.61M |
| September 30, 2016 | 5.936M |
| June 30, 2016 | 1.206M |
| March 31, 2016 | 0.9965M |
| December 31, 2015 | 24.51M |
| September 30, 2015 | 1.077M |
| June 30, 2015 | 1.081M |
| March 31, 2015 | 0.9601M |
| December 31, 2014 | 1.058M |
| September 30, 2014 | 10.35M |
| June 30, 2014 | 0.7891M |
| March 31, 2014 | 15.60M |
| December 31, 2013 | 0.5796M |
| September 30, 2013 | 0.4119M |
| June 30, 2013 | 0.1892M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | 6.273M |
| June 30, 2012 | 11.38M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-15.69M
Minimum
Dec 2020
43.16M
Maximum
Sep 2023
5.957M
Average
2.743M
Median
Revenue (Quarterly) Benchmarks
| Novo Nordisk AS | 10.51B |
| Genmab AS | 816.44M |
| Ascendis Pharma AS | 38.76M |
| Galecto Inc | -- |
| Evaxion Biotech AS | 3.017M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.26M |
| Total Expenses (Quarterly) | 52.14M |
| EPS Diluted (Quarterly) | -0.5556 |
| Enterprise Value | 6.972B |
| Profit Margin (Quarterly) | -6.03K% |
| Earnings Yield | -2.12% |
| Normalized Earnings Yield | -1.924 |